Stability or versatility: transitions in fentanyl routes of administration
Jeff Ondocsin, Sarah G. Mars, Nicole Holm, Allison Schlosser, Jason Fessel, Amanda Cowan, Michael Duke, Daniel Ciccarone

TL;DR
This paper explores how people in San Francisco are shifting how they use fentanyl, including switching from injecting to smoking, and the reasons behind these changes.
Contribution
The study provides new qualitative insights into recent trends of fentanyl administration transitions and their social and health implications.
Findings
Participants transitioned from injecting to smoking fentanyl due to availability shifts and health concerns.
Smoking fentanyl is often used in public or for convenience, while injecting is preferred for faster effects and privacy.
Some users combine smoking and injecting for flexibility, while others return to injecting due to instability in smoking transitions.
Abstract
Transitions in how people use drugs have long influenced drug use research and the policy landscape. In unregulated drug markets, route of administration (ROA) transitions from injecting opioids to non-injecting modes of use, sometimes called reverse transitions, are rare but have been documented historically, driven by local characteristics including social networks and drug market factors. National and local data find ROA transitions are on the rise in the US. We investigated patterns of ROA transitions, including personal and market-based motivations and perceived effects and health benefits. We examined trends in San Francisco’s drug market, including changes in substance use administration patterns and the forces motivating people who use drugs to adopt alternate or multimodal dosing strategies. We conducted 32 semi-structured qualitative interviews in 2022 using rapid assessment…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHIV, Drug Use, Sexual Risk · Opioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes
